INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Ergomed's Solutions To The Challenges of Oncology Trials
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
-
Accelerating Clinical Trials Through Streamlined Confidential Disclosure Agreements
In this presentation, Dr. Christine Senn addresses the persistent challenge of study startup delays by focusing on a primary legal hurdle: the Confidential Disclosure Agreement (CDA).
-
Specialized Site Network For Early-Phase Oncology Success
Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Yet, too often, the operational burden falls on clinical sites―already overworked and stretched thin. Within large, volume-driven CRO networks, this creates a system that prioritizes scale over quality, offering minimal site support, delaying timelines, and ultimately compromising trial outcomes.
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
From Friction To Partnership: What It Really Takes To Become The Sponsor of Choice7/17/2026
Sponsors depend on sites to recruit patients, execute protocols, and collect high-quality data. In this candid panel discussion, we explore what makes sites want to work with a sponsor.
-
Switching IRT/RTSM Providers Shouldn't Feel Like Moving Mountains | Korio Makes It Easy3/25/2026
Unveil how structured, repeatable processes can turn RTSM migrations from high‑risk undertakings into predictable transitions.
-
Faster Starts, Stronger Finish: Operational Excellence In NSCLC5/22/2026
In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Vendor Selection Bias: Why Structured Decisions Often Fail12/22/2025
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.
-
Worldwide Flex provides flexible, scalable solutions and services to enhance our clients’ outsourcing needs. We are a specialized provider of multi-therapeutic functional solutions delivered by our experts.
-
Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.
-
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.
-
Making it easier to participate in and run clinical trials with simplified patient scheduling and appointment reminders.